CAM
SKBI

ClariVest Asset Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

ClariVest Asset Management’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,720
Closed -$53K – 682
2015
Q2 		$53K Hold
19,720
– – ﹤0.01% 468
2015
Q1 		$78K Hold
19,720
– – ﹤0.01% 464
2014
Q4 		$84K Hold
19,720
– – ﹤0.01% 427
2014
Q3 		$82K Buy
19,720
+15,704
+391% +$85.2K ﹤0.01% 450
2014
Q2 		$30K Buy
+4,016
New +$24K ﹤0.01% 461

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ClariVest Asset Management's SKBI Position: Q3 2015 in Review

ClariVest Asset Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 19,720 shares — an estimated $53K sold.

ClariVest Asset Management first reported a position in SKBI in Q2 2014 and held it in 5 quarters. The position peaked at $84K in Q4 2014. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

  • ClariVest Asset Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
  • ClariVest Asset Management sold 19,720 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015, an estimated $53K.
  • ClariVest Asset Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2014 and held it in 5 quarters.
  • ClariVest Asset Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $84K in Q4 2014.
  • 10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on ClariVest Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.